Related references
Note: Only part of the references are listed.Decreased striatal adenosine A2A-dopamine D2receptor heteromerization in schizophrenia
Marta Valle-Leon et al.
NEUROPSYCHOPHARMACOLOGY (2021)
NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms
Melissa A. Snyder et al.
SCHIZOPHRENIA RESEARCH (2020)
Conventional and Novel Pharmacological Approaches to Treat Dopamine-Related Disorders: Focus on Parkinson's Disease and Schizophrenia
Miguel Perez de la Mora et al.
NEUROSCIENCE (2020)
The origin of NMDA receptor hypofunction in schizophrenia
Kazu Nakazawa et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task
David Phenis et al.
PSYCHOPHARMACOLOGY (2020)
Multiple Adenosine-Dopamine (A2A-D2 Like) Heteroreceptor Complexes in the Brain and Their Role in Schizophrenia
Dasiel O. Borroto-Escuela et al.
CELLS (2020)
Potential antipsychotic action of the selective agonist of adenosine A1 receptors, 5′-Cl-5′-deoxy-ENBA, in amphetamine and MK-801 rat models
Krystyna Ossowska et al.
PHARMACOLOGICAL REPORTS (2020)
N-Acetylcysteine Inhibits Kynurenine Aminotransferase II
T. Blanco-Ayala et al.
NEUROSCIENCE (2020)
Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations
Ather Muneer
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2020)
Inhibition of kynurenine aminotransferase II attenuates hippocampus-dependent memory deficit in adult rats treated prenatally with kynurenine
Ana Pocivavsek et al.
HIPPOCAMPUS (2019)
Adenosine heteroreceptor complexes in the basal ganglia are implicated in Parkinson's disease and its treatment
Dasiel O. Borroto-Escuela et al.
JOURNAL OF NEURAL TRANSMISSION (2019)
Purinergic system in psychiatric diseases
A. Cheffer et al.
MOLECULAR PSYCHIATRY (2018)
Prenatal kynurenine treatment in rats causes schizophrenia-like broad monitoring deficits in adulthood
Britta Hahn et al.
PSYCHOPHARMACOLOGY (2018)
Relevance of Alternative Routes of Kynurenic Acid Production in the Brain
L. A. Ramos-Chavez et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
A2AR-D2R Heteroreceptor Complexes in Cocaine Reward and Addiction
Dasiel O. Borroto-Escuela et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
The kynurenine pathway in schizophrenia and bipolar disorder
Sophie Erhardt et al.
NEUROPHARMACOLOGY (2017)
Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis
Eric Plitman et al.
SCHIZOPHRENIA BULLETIN (2017)
Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health
Igor Cervenka et al.
SCIENCE (2017)
Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease
Dasiel O. Borroto-Escuela et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future
Peng Li et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Purinergic receptors in psychiatric disorders
Ute Kruegel
NEUROPHARMACOLOGY (2016)
Kynurenine Aminotransferase Isozyme Inhibitors: A Review
Alireza Nematollahi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Glutamate and dopamine in schizophrenia: An update for the 21st century
Oliver Howes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Comorbidities in Neurology: Is adenosine the common link?
Detlev Boison et al.
NEUROPHARMACOLOGY (2015)
The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies
Wei Hu et al.
YEAR IN NEUROLOGY AND PSYCHIATRY (2015)
Reduction of Brain Kynurenic Acid Improves Cognitive Function
Rouba Kozak et al.
JOURNAL OF NEUROSCIENCE (2014)
Astrocytic adenosine: from synapses to psychiatric disorders
Dustin J. Hines et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia
Jared W. Young et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Kynurenic acid, by targeting 7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo
Sarah Beggiato et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
Adenosine hypothesis in schizophrenia and bipolar disorder: A systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators
Tomoya Hirota et al.
SCHIZOPHRENIA RESEARCH (2013)
An expanding range of targets for kynurenine metabolites of tryptophan
Trevor W. Stone et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia
Hai-Ying Shen et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery
Flavio Moroni et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Kynurenines in the mammalian brain: when physiology meets pathology
Robert Schwarcz et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Adenosine hypothesis of schizophrenia - Opportunities for pharmacotherapy
Detlev Boison et al.
NEUROPHARMACOLOGY (2012)
Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
Klas R. Linderholm et al.
SCHIZOPHRENIA BULLETIN (2012)
Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors
Hui Zhang et al.
BASAL GANGLIA (2012)
Adenosine A1 Receptors in the Central Nervous System: Their Functions in Health and Disease, and Possible Elucidation by PET Imaging
S. Paul et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia
Korrapati V. Sathyasaikumar et al.
SCHIZOPHRENIA BULLETIN (2011)
Crystal Structure-Based Selective Targeting of the Pyridoxal 5′-Phosphate Dependent Enzyme Kynurenine Aminotransferase II for Cognitive Enhancement
Franca Rossi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
CORTICAL KYNURENIC ACID BI-DIRECTIONALLY MODULATES PREFRONTAL GLUTAMATE LEVELS AS ASSESSED BY MICRODIALYSIS AND RAPID ELECTROCHEMISTRY
A. Konradsson-Geuken et al.
NEUROSCIENCE (2010)
Cortical Kynurenine Pathway Metabolism: A Novel Target for Cognitive Enhancement in Schizophrenia
Ikwunga Wonodi et al.
SCHIZOPHRENIA BULLETIN (2010)
Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release
A. Zmarowski et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Dopamine D2 and Adenosine A2A Receptors Regulate NMDA-Mediated Excitation in Accumbens Neurons Through A2A-D2 Receptor Heteromerization
Karima Azdad et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology
K. Fuxe et al.
BRAIN RESEARCH REVIEWS (2008)
Novel pharmacological targets based on receptor heteromers
Rafael Franco et al.
BRAIN RESEARCH REVIEWS (2008)
Potential role of adenosine A2A receptors in the treatment of schizophrenia
Jadwiga Wardas
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function
Kjell Fuxe et al.
PHYSIOLOGY & BEHAVIOR (2007)
Kynurenic acid leads, dopamine follows: A new case of volume transmission in the brain?
H. -Q. Wu et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry
Paolo Guidetti et al.
GLIA (2007)
Modulation of D2R-NR2B interactions in response to cocaine
Xian-Yu Liu et al.
NEURON (2006)
Repeated injection of MK801: An animal model of schizophrenia?
EM Eyjolfsson et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers
F Ciruela et al.
JOURNAL OF NEUROSCIENCE (2006)
Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications
Diogo R. Lara et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia
LK Nilsson et al.
SCHIZOPHRENIA RESEARCH (2005)
Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases
LF Agnati et al.
NEUROMOLECULAR MEDICINE (2005)
Neuronal A1 receptors mediate increase in extracellular kynurenic acid after local intrastriatal adenosine infusion
HQ Wu et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Schizophrenia: a purinergic hypothesis
DR Lara et al.
MEDICAL HYPOTHESES (2000)
Share Paper
